EXEMESTANE vs OGIVRI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 13, 2026·How we rate

Possible drug interaction. EXEMESTANE and OGIVRI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	EXEMESTANE	OGIVRI
Rating	72/100	66/100
Pharmacy pays	~$18.36 /30	—
Type	RX	RX
Active ingredient	EXEMESTANE	TRASTUZUMAB-DKST
Manufacturer	Rising	Mylan Gmbh
Dosage forms	Tablet	Injectable, Kit
Drug class	Aromatase Inhibitor	—
Boxed warning	None	Boxed warning
Treats	Breast Neoplasms	Breast Neoplasms, Gastrointestinal Neoplasms

exemestane ogivri

Rating

72/100

66/100

Pharmacy pays

~$18.36 /30

—

Type

Active ingredient

EXEMESTANE

TRASTUZUMAB-DKST

Manufacturer

Rising

Mylan Gmbh

Dosage forms

Tablet

Injectable, Kit

Drug class

Aromatase Inhibitor

—

Boxed warning

None

Boxed warning

Treats

Breast Neoplasms

Breast Neoplasms, Gastrointestinal Neoplasms

Frequently asked questions

Which is better-rated, Exemestane or Ogivri?

By our independent rating, Exemestane scores higher — 3.6 vs 3.3 out of 5 for Ogivri. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Exemestane and Ogivri?

Exemestane contains Exemestane, while Ogivri contains Trastuzumab-Dkst — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.